BioRender 아이콘

TA-MUC1

TA-MUC1 - Editable icon of a TA-MUC1 membrane bound protein in a schematic representation
[{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a953749cad1a/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a953749cad1a/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a904bc9cad19/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a904bc9cad19/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a95d0a9cad18/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a95d0a9cad18/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a91c8a9cad17/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a91c8a9cad17/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a962c19cad16/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a962c19cad16/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92f419cad15/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92f419cad15/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9a3b79cad14/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9a3b79cad14/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9ff769cad13/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9ff769cad13/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92b439cad12/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92b439cad12/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a91ca89cad11/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a91ca89cad11/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a951a09cad10/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a951a09cad10/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9b5229cad0f/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9b5229cad0f/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9146b9cad0e/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9146b9cad0e/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a93c5c9cad0d/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a93c5c9cad0d/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9b0509cad0c/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9b0509cad0c/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9284e9cad0b/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9284e9cad0b/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a96d219cad0a/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a96d219cad0a/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a94a0e9cad09/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a94a0e9cad09/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a97f4e9cad08/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a97f4e9cad08/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a952b39cad07/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a952b39cad07/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9f09d9cad06/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9f09d9cad06/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a925e59cad05/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a925e59cad05/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a963379cad04/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a963379cad04/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a954e39cad03/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a954e39cad03/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a94cfb9cad02/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a94cfb9cad02/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a994d09cad01/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a994d09cad01/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a946749cad00/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a946749cad00/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a934c99cacff/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a934c99cacff/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a907989cacfe/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a907989cacfe/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9accd9cacfd/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9accd9cacfd/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a998de9cacfc/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a998de9cacfc/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9001b9cacfb/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9001b9cacfb/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9cac39cacfa/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9cac39cacfa/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92fd59cacf9/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92fd59cacf9/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a91eb39cacf8/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a91eb39cacf8/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a980f09cacf7/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a980f09cacf7/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a96ec69cacf6/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a96ec69cacf6/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9f96f9cacf5/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9f96f9cacf5/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9bdc89cacf4/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9bdc89cacf4/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9ffbc9cacf3/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9ffbc9cacf3/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a919ad9cacf2/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a919ad9cacf2/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a922539cacf1/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a922539cacf1/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9b0ea9cacf0/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9b0ea9cacf0/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a939189cacef/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a939189cacef/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a981c59cacee/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a981c59cacee/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92df09caced/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92df09caced/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a908609cacec/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a908609cacec/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9300e9caceb/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9300e9caceb/65c0fcbfdd873ad09e4e1d03.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍
page dashboard

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
TA-MUC1,mucin,muc,muc1,tumor,tumour,associated,tumor associated,membrane bound,bound,membrane,SEA domain,glycosylated sugar chain,glycosylated,glycoconjugates,sugar,glycan,Tn,sTn,sTF,chain,glycans,cytoplasmic tail,gel,secretion,lubrication,cell signaling,chemical barrier,inhibitory,mineralization,epithelial,TA-MUC1
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

TA-MUC1 icon JPEG

TA-MUC1 icon PNG

TA-MUC1 icon SVG

TA-MUC1 icon GIF

BioRender 아이콘 FAQ

How are scientists using the TA-MUC1 icon in their work?

BioRender users often use the TA-MUC1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the TA-MUC1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the TA-MUC1 icon customizable in BioRender?

Most icons in BioRender, including the TA-MUC1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the TA-MUC1 icon for publication or presentations?

Yes, figures containing the TA-MUC1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the TA-MUC1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the TA-MUC1 icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this TA-MUC1 icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon